This inventor holds 2 USPTO granted patents. Top assignee: Oy Jurilab Ltd.. Active years: 2004-2007.
Company Filing History:
Years Active: 2004-2007
Title: Marja Marchesani: Innovator in Genetic Research
Introduction
Marja Marchesani is a prominent inventor based in Kuopio, Finland. She has made significant contributions to the field of genetic research, particularly in the development of innovative methods for detecting health risks associated with various diseases. With a total of 2 patents to her name, her work is paving the way for advancements in personalized medicine.
Latest Patents
One of her latest patents is focused on a DNA molecule encoding a variant paraoxonase. This invention is directed to a DNA sequence comprising a nucleotide sequence encoding a variant paraoxonase protein. It also includes a method and a kit for detecting the risk of cancer, coronary or cerebrovascular disease, hypertension, type 2 diabetes, dementia, joint arthrosis, cataract, or sensitivity to organophosphorus compounds in a subject. The method involves isolating genomic DNA from the subject, determining the allelic pattern for the codon 102 of the paraoxonase encoding PON1 gene in the genomic DNA, and identifying the Ile101Val mutation, which indicates an increased risk. Furthermore, this invention relates to transgenic animals comprising a human DNA molecule encoding the variant paraoxonase and a method of phenotype-targeted gene sequencing.
Career Highlights
Marja Marchesani is currently associated with Oy Jurilab Ltd., where she continues to innovate and contribute to the field of genetic research. Her work is instrumental in developing new diagnostic tools that can significantly impact patient care and treatment options.
Collaborations
She collaborates with notable colleagues, including Jukka T Salonen and Tomi-Pekka Tuomainen, to further enhance her research and development efforts.
Conclusion
Marja Marchesani's contributions to genetic research and her innovative patents are vital in advancing our understanding of health risks and developing targeted therapies. Her work exemplifies the importance of innovation in the medical field.